Maksim Parfyonov is a Pediatric Epilepsy Fellow at the Cleveland Clinic in Cleveland, Ohio. His research interests include treatment-resistant epilepsy and genetic causes of pediatric epilepsy.
He currently leads the EPBiome study , a multi-center trial investigating the role of the gut microbiome in the efficacy of ketogenic diet, which is supported by a grant from the Weston Foundation. His clinical interests mirror his research interests and include treatment-refractory epilepsy, ketogenic diet, and surgical management of epilepsy.
MSc, Biomedical & Health Informatics (in progress), 2023-present
Case Western Reserve University
Clinical Neurophysiology Fellowship, 2023
Cleveland Clinic
Epilepsy Fellowship, 2022
Cleveland Clinic
Pediatric Neurology Residency, 2017-2022
British Columbia Children's Hospital
MD, 2013-2017
University of British Columbia
BSc in Neuroscience & Biochemistry, 2013
Simon Fraser University